Liza Meza
Nurse Practitioner · Whittier, CANPI 1326670092
Payments from drug & device makers
Across 202 payments — averaging $21.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$510
- Lilly USA, LLC$487
- Amgen$411
- AstraZeneca$280
- AbbVie$279
- Pfizer$250
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,20198%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $510 |
| Lilly USA, LLC | 23 | $487 |
| Amgen | 18 | $411 |
| AstraZeneca | 15 | $280 |
| AbbVie | 14 | $279 |
| Pfizer | 12 | $250 |
| GSK | 10 | $203 |
| Boehringer Ingelheim | 6 | $164 |
| Astellas Pharma US Inc | 5 | $158 |
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $121 |
| Novartis | 6 | $120 |
| Sumitomo Pharma America, Inc. | 4 | $106 |
| Shield Therapeutics Inc | 4 | $99 |
| Lundbeck LLC | 4 | $96 |
| Johnson & Johnson | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Neurocrine Biosciences, Inc. | 2 | $58 |
| Eisai Inc. | 2 | $57 |
| Merck | 2 | $49 |
| Bayer | 2 | $44 |
| Avanir Pharmaceuticals, Inc. | 2 | $40 |
| Mannkind Corporation | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Biogen | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Abiomed | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$104
How this compares
$4,267 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 60 | $45,948 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $14,021 |
| MyrbetriqMirabegron | 13 | $6,636 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 13 | $4,679 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $4,335 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 106 | $2,161 |
| Atorvastatin Calcium | 161 | $1,757 |
| Levothyroxine Sodium | 107 | $1,496 |
| Oxcarbazepine | 12 | $781 |
| Losartan Potassium | 71 | $711 |
| Potassium Chloride | 25 | $651 |
| Memantine Hcl | 19 | $634 |
| Metformin Hcl | 65 | $583 |
| Valsartan | 14 | $575 |
| Hydroxyzine Hcl | 61 | $435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $250 | $45,94860 claims |
| GSKTrelegy Ellipta | $203 | $14,02123 claims |
| Astellas Pharma US IncMyrbetriq | $158 | $6,63613 claims |
| Lilly USA, LLCHumulin 70-30 | $487 | $4,67913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Whittier
- Emily MalmWhittier$32K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.